The Interventional Oncology Center

Filter Your Results




Study Supporting Prostate Artery Embolization Presented at SIR

March 24, 2014 -- The Society of Interventional Radiology (SIR) announced findings from a study demonstrating that 72% of men with benign prostatic hyperplasia who were treate…

Y-90 Radioembolization Studied to Treat Breast Cancer Liver Metastases

March 24, 2014 -- The Society of Interventional Radiology (SIR) announced that yttrium-90 (Y-90) radioembolization of the artery that supplies the liver shows promise in treat…

FDA Clears Hansen’s Magellan 6-F Robotic Catheter

February 11, 2014 -- Hansen Medical, Inc. (Mountain View, CA), announced it has received US Food and Drug Administration clearance for its smaller-diameter Magellan 6-F roboti…

Study Supports Prostate Artery Embolization to Treat BPH

January 22, 2014 -- Research on more than 100 patients suggests that men with benign prostate hyperplasia (BPH) can achieve relief of symptoms with prostate artery emboli…

Boston Scientific’s Direxion Torqueable Microcatheter Receives FDA Clearance and CE Mark Approval

November 19, 2013 -- Boston Scientific Corporation (Natick, MA) announced that it has received US Food and Drug Administration clearance and European CE Mark approval for…

Cook Launches Cantata Superselective Microcatheter

March 28, 2011 -- Cook Medical (Bloomington, IN) announced the launch of the Cantata superselective microcatheter at the Society of Interventional Radiology’s 36th Annua…



2017 Device Guide

This Device Guide offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.